Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | 20,000 | reported | 28 Jun 2022 | tx 6+78,716−10,729 |
| Spyre Therapeutics, Inc. | 8,026 | reported | 27 May 2026 | tx 9+178,709−7,859 |
| Blueprint Medicines Corp | 0 | reported | 17 Jul 2025 | tx 303+1,673,412−2,356,446 |
| Kymera Therapeutics, Inc. | 0 | reported | 08 Dec 2025 | tx 28+152,539−72,698 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 8,026 | 0.00 USD | deriv |
| 08 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 2,252 | 90.30 USD | |
| 08 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 2,748 | 89.32 USD | |
| 08 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 5,000 | 14.18 USD | |
| 08 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 13 Oct 2025 | EXERCISE | Kymera Therapeutics, Inc. | 5,000 | 10.34 USD | |
| 13 Oct 2025 | SALE | Kymera Therapeutics, Inc. | 5,000 | 59.19 USD | |
| 13 Oct 2025 | EXERCISE | Kymera Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 17 Jul 2025 | TENDER | Blueprint Medicines Corp | 144,755 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,777 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 92,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 170,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 110,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,570 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 80,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 15,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,300 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 90,000 | — | deriv |
| 25 Jun 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Blueprint Medicines Corp | 3,902 | 128.12 USD | |
| 03 Jun 2025 | SALE | Kymera Therapeutics, Inc. | 6,349 | 49.00 USD | |
| 03 Jun 2025 | EXERCISE | Kymera Therapeutics, Inc. | 6,349 | 10.34 USD | |
| 03 Jun 2025 | EXERCISE | Kymera Therapeutics, Inc. | 6,349 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 27 May 2025 | SALE | Blueprint Medicines Corp | 4,350 | 101.02 USD |